US approves remdesivir drug to treat Covid-19 patients, says Trump
The US Food and Drug Administration (FDA) has granted authorisation to Gilead Sciences Inc. for emergency use of its experimental antiviral drug remdesivir to treat patients with Covid-19, President Donald Trump announced on Friday.